India’s daily COVID count crosses 1-lakh, Omicron tally at 3,000 – ET HealthWorld

New Delhi: India on Friday crossed the one-lakh mark in its daily COVID-19 tally with 1,17,100 new cases being reported and 302 deaths in the last 24 hours. According to the latest updated data from the Union ministry of health and family affairs, the country’s current active caseload currently stands at 3,71,363. The last time India had recorded more than a lakh cases in a day was on June 6, 2021. India also reports second death of a 50-year-old woman, a resident of Agalpur in Bolangir district who had tested…

Read More

India’s Omicron tally stands at 2,630 cases; R naught value is higher than 2nd wave – ET HealthWorld

New Delhi : India has reported 2,630 cases of the new Omicron variant of COVID-19 so far, the Union health ministry data stated. The Omicron tally in the country reached 2,630, with Maharashtra (797) topping the count, followed by Delhi (465), Rajasthan (236) and Kerala (234). On Wednesday, the Centre confirmed the first Omicron-related death in the country – a 74-year-old man with comorbidities, who succumbed to the virus last week in Rajasthan’s Udaipur. India is experiencing a rise in the number of COVID-19 cases, driven by Omicron, the Centre…

Read More

Delta announces its presence physically, Omicron is asymptomatic – ET HealthWorld

New Delhi: As the cases of Omicron, the highly transmissible variant, are surging globally, and the symptoms of Delta and Omicron are inter-related, it is difficult to differentiate between the two. Still, a lot more is yet to be known about Omicron, inform doctors. The Omicron variant – or B.1.1.529 – which has been designated as a variant of concern by the World Health Organisation (WHO) has been spreading rapidly, despite the symptoms being mild. Speaking to ETHealthworld, doctors informed that the common symptoms of Omicron variant were sore throat,…

Read More

Indian vaccines should be used as boosters without any delay, say experts – ET HealthWorld

Indian vaccines should be used as booster shots without delay to combat the Omicron variant, public health experts said, instead of waiting for mRNA-based ones that are currently not available in the country. This comes even as the government’s advisory group on Covid-19 is awaiting data from the National Institute of Virology (NIV), Pune before it considers recommending booster doses. Experts said mRNA vaccines work best as boosters against Covid-19, but in the absence of these, people who have received Serum Institute of India (SII)’s Covishield should get Bharat Biotech’s…

Read More

Omicron driven third wave in India likely to peak in Feb: Covid Supermodel Panel – ET HealthWorld

Daily COVID-19 caseload in India that is currently around 7,500 infections is expected to increase once the Omicron starts displacing Delta as the dominant variant, informed members of the National COVID-19 Supermodel Committee and predicted the third wave in India early year. Vidyasagar, who is also the head of the National COVID-19 Supermodel Committee, said that India will have Omicron’s third wave but it will be milder than the second wave. “Third wave is likely to arrive early next year in India. It should be milder than the second wave…

Read More

Covid-19: Anthony Fauci warns of bleak winter with Omicron ‘raging through the world’ – ET HealthWorld

WASHINGTON: Top US pandemic advisor Anthony Fauci on Sunday warned of a bleak winter ahead as the Omicron coronavirus variant spurs a new wave of infections globally, sparking restrictions and concerns over hospital capacity. “One thing that’s very clear… is (Omicron’s) extraordinary capability of spreading,” Fauci told NBC News. “It is just… raging through the world.” Since it was first reported in South Africa in November, Omicron has been identified in dozens of countries, prompting many to reimpose travel restrictions and other measures. Despite indications it is not more severe…

Read More

55 Indian companies can make mRNA vax: Report – ET HealthWorld

MUMBAI: With the emergence of the highly-transmissible Omicron variant and an urgent need for boosters and more efficacious jabs, a global report for the first time has identified over 55 domestic companies including Biocon, Dr Reddy’s, Sun Pharma, Reliance LifeSciences, Zydus Cadila, Intas and Lupin, which could potentially manufacture the messenger or mRNA vaccines. The report by AccessIBSA and Médecins Sans Frontières (MSF), stresses the need to diversify and expand manufacture of mRNA vaccines to accelerate the roll-out of billions of doses possibly within six months, importantly, under a license…

Read More

Third wave likely early next year: Health experts – ET HealthWorld

PATNA: With the exponential rise of Omicron cases across the world the third wave of Covid-19 is almost a certainty now, say health experts. Even though the state has not reported any Omicron case till date, the number of people infected with this new variant is rising considerably in different states and is likely to hit Bihar sooner or later. Health experts predict that a third wave of Covid-19 may be witnessed early next year if the present trend continues. All India Institute of Medical Sciences-Patna Covid-19 in-charge Dr Sanjeev…

Read More

Take all measures to prevent further spread of Omicron: WHO – ET HealthWorld

New Delhi: With seven countries in South-East Asia Region confirming cases of the new COVID-19 variant Omicron, the World Health Organization (WHO) today emphasized on urgent scale up of public health and social measures to curtail its further spread. Adding to the conversation about protecting the least protected, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region, emphasised that countries can – and must – prevent the spread of Omicron with the proven health and social measures. Our focus must continue to be to protect the least protected and…

Read More

Centre to review allowing booster doses, vaccination for children by end of month – ET HealthWorld

NEW DELHI: The Centre will review its Covid vaccination plan at the end of December by when it aims to have fully vaccinated 65% of the adult population. The discussion will include booster or third dose for high-risk people as well as vaccination for children, a senior official source said. “We will review the programme in December end. The picture will be clearer then in terms of Omicron. At present our priority is to maximise coverage of second dose among adults, which includes people who are at risk also,” the…

Read More